Esaote Pushes Into Neurosurgery and U.S. Cardiology Channels While Rolling Out New Ultrasound Platforms

Image

SHERIDAN, WYOMING - April 14, 2026 - Esaote, one of the world's leading manufacturers of dedicated MRI and medical diagnostic imaging systems, has executed a series of product launches and a strategic distribution partnership over recent months. The company unveiled the MyLab™E85 GTS Edition featuring exclusive PAM technology at the 2026 European Association of Urology congress, presented new ultrasound and enterprise imaging capabilities at the European Congress of Radiology in March, and entered the neurosurgery segment with the I-Genius intraoperative MRI system at the 25th EANS Annual Congress. In November 2025, Esaote and Schiller Americas formalized a partnership to expand the cardiology imaging sales channel in the United States. Taken together, these moves represent a coordinated push across specialties, geographies, and imaging modalities.

New Ultrasound Platforms Target Urology and Radiology

Esaote's product rollout centres on two new GTS Edition ultrasound systems. The MyLab™E85 GTS Edition, shown at EAU 2026, incorporates exclusive PAM technology positioned to advance precision in urological imaging - marking a distinct clinical application for the platform. At ECR 2026 on March 5, the company simultaneously presented the MyLab™E85 GTS and the MyLab™C30 GTS Edition alongside advances in enterprise imaging and interventional radiology ultrasound. The parallel deployment across two major European congresses reflects a structured market introduction sequence. Esaote's broader MyLab™ ultrasound line currently spans more than twenty platforms covering point-of-care, shared-service, and high-end clinical configurations.

Business Impact

The November 2025 agreement with Schiller Americas, headquartered in Fishers, Indiana, extends Esaote's cardiology imaging reach through an established U.S. distribution network. The partnership targets expansion of the sales channel in what remains one of the most competitive and high-value medical imaging markets globally. Esaote also entered a new clinical segment with the I-Genius intraoperative MRI system, presented at the 25th EANS Annual Congress. The system represents the company's first positioning in neurosurgery, adding intraoperative capability to an existing MRI line-up that includes the Magnifico Open, S-scan, G-scan Brio, G-scan, O-scan, and O-scan SMART platforms. Expanding across cardiology distribution and neurosurgical imaging in the same period increases Esaote's addressable clinical base considerably.

Healthcare IT as a Commercial Differentiator

Esaote competes as a full-stack diagnostic provider through its Healthcare IT subsidiary, Ebit s.r.l., which develops the Suitestensa software suite. The portfolio spans cardiovascular information systems, enterprise imaging, PACS, VNA, RIS, interventional radiology, EP lab management, remote cardiac device management, and an AI-enabled module designated Suitestensa fAInd. For hospital procurement teams evaluating consolidated vendor relationships, the ability to source imaging hardware and clinical IT from a single supplier carries operational and budget implications. The enterprise imaging segment in particular positions Esaote alongside larger radiology IT vendors in tender evaluations.

ESG Certification and Governance

Esaote S.p.A. and Ebit s.r.l. have both received UNI/PdR 125:2022 certification, the Italian standard for gender equality in the workplace. The dual certification across the parent company and its healthcare IT subsidiary formalises the group's ESG commitments in an area increasingly scrutinised during institutional supplier assessments and public procurement evaluations across European markets. The company's sustainability framework encompasses equity and diversity, environmental impact, workforce development, and employee well-being - factors that influence positioning in markets with ESG-linked supplier qualification criteria.

Key facts:

  • MyLab™E85 GTS Edition with exclusive PAM technology debuted at EAU 2026 for urological imaging
  • MyLab™E85 GTS and MyLab™C30 GTS Edition presented at ECR 2026 on March 5, 2026
  • Esaote-Schiller Americas cardiology imaging distribution partnership announced November 13, 2025, Fishers, IN
  • I-Genius intraoperative MRI system marks Esaote's entry into the neurosurgery segment
  • Esaote S.p.A. and Ebit s.r.l. achieved UNI/PdR 125:2022 gender equality certification
Published by:
fairsonline_team
Target market(s)
Event